ECG Markers of Positive Drug Challenge With Ajmaline in Patients With Brugada Syndrome
A prominent S‐wave in lead II on a nondiagnostic baseline ECG is a powerful predictor for unmasking Brugada syndrome during an ajmaline challenge. This subtle sign enhances patient selection for provocation testing and aids in risk stratification, particularly in familial screening.
Erol Tülümen +9 more
wiley +1 more source
Concentration-QT modeling demonstrates that the selective mineralocorticoid receptor modulator, balcinrenone (AZD9977), does not prolong QT interval. [PDF]
Sundell J +6 more
europepmc +1 more source
Prolonged corrected QT interval is associated with cardiac sympathetic nervous function overactivity in patients with severe aortic stenosis: assessment by 123I-metaiodobenzylguanidine myocardial scintigraphy. [PDF]
Fukuda Y +6 more
europepmc +1 more source
Surfing the T Wave: A Primer on ECG T Wave Morphologies Encountered in Clinical Trials and Impact on the QT Interval and Patient Safety. [PDF]
Lester RM, Paglialunga S.
europepmc +1 more source
Impact of hypokalemia on Brugada syndrome: case report unveiling mechanisms beyond QT interval prolongation. [PDF]
Siregar MNI, Wahidji VH.
europepmc +1 more source
Investigating the effects of remdesivir on corrected QT interval in patients with severe COVID-19 disease: a historical cohort study. [PDF]
Saffar H, Nabati M, Saffar N, Yazdani J.
europepmc +1 more source
Differential diagnostic value of P wave dispersion and QT interval dispersion between psychogenic pseudosyncope and vasovagal syncope in children and adolescents. [PDF]
Huang Z +8 more
europepmc +1 more source

